Prenatal screens: Blood type O-positive, antibody negative, rubella immune, RPR nonreactive, hepatitis B surface antigen negative, group B strep status unknown.
The mother developed gestational diabetes and became insulin dependent.
She was treated with magnesium sulfate and terbutaline.
She was also treated with betamethasone.
On the day of delivery, she developed progressive cervical dilatation and was taken to repeat cesarean section.
She was admitted to the neonatal intensive care unit for treatment of prematurity.
The mother was transferred from [**Name (NI) 1474**] Hospital for treatment and delivery.
Fluid, electrolytes, and nutrition: [**Female First Name (un) 52041**] had some initial     hypoglycemia that resolved with intravenous 10% dextrose     in water.
Enteral feeds were started on day of life 2 and     gradually advanced to full volume by gavage.
Feedings are all po now, ad lib taking approximately 150ml/kg/d of [**Doctor Last Name **] 24 or breastmilk fortified with Similac powder to 24kcl/oz.
She received lactation consultation.
Infectious disease: Due to her prematurity and unknown     group B strep status of her mother, [**Name (NI) 52041**] was evaluated     for sepsis upon admission to the neonatal intensive care     unit.
A     blood culture was obtained prior to starting intravenous     ampicillin and gentamicin.
She was not treated with phototherapy.
Hepatitis B vaccine was given on [**2130-5-29**].
Feeding: 150 mL per kilogram per day of Similac Special Care formula 24 or breast milk 24 calories per ounce if breatmilk is available.
No immunizations have been administered.
Immunizations recommended: Synagis RSV prophylaxis should     be considered from [**Month (only) **] through [**Month (only) 958**] for infants who     meet any of the following 3 criteria: 1) born at less     than 32 weeks; 2) born between 32-35 weeks with 2 of the     following: Daycare during RSV season, a smoker in the     household, neuromuscular disease, airway abnormalities,     or school-age siblings; or 3) with chronic lung disease.
Influenza immunization is recommended annually in the fall for all infants once they reach 6 months of age.
Before this age and for the 1st 24 months of the child's life, immunization against influenza is recommended for household contacts and out-of-home caregivers.
